Profile data is unavailable for this security.
About the company
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
- Revenue in CNY (TTM)2.17bn
- Net income in CNY380.97m
- Incorporated2000
- Employees2.32k
- LocationCathay Biotech Inc4th Floor, Building 51690 Cailun Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
- Phone+86 2 150801916
- Fax+86 2 150801386
- Websitehttps://www.cathaybiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fujian Kuncai Material Technology Co Ltd | 817.94m | 72.63m | 20.48bn | 787.00 | 281.91 | 11.00 | -- | 25.03 | 0.1552 | 0.1552 | 1.75 | 3.98 | 0.2149 | 0.672 | 4.08 | 1,039,314.00 | 2.05 | 6.75 | 2.86 | 8.21 | 33.57 | 38.88 | 9.54 | 19.98 | 0.264 | 2.78 | 0.5084 | 7.85 | -8.27 | 11.79 | -38.77 | -5.71 | 37.07 | -- |
HuBei XingFa Chemical Group Co Ltd | 28.11bn | 1.38bn | 23.38bn | 14.59k | 17.79 | 1.12 | -- | 0.8318 | 1.19 | 1.19 | 24.02 | 18.95 | 0.6522 | 10.05 | 25.88 | 1,926,607.00 | 3.22 | 8.10 | 4.52 | 13.69 | 14.94 | 22.93 | 4.93 | 11.72 | 0.4561 | 10.23 | 0.3777 | 21.95 | -7.28 | 9.50 | -76.44 | 31.74 | 20.59 | 24.57 |
Cathay Biotech Inc | 2.17bn | 380.97m | 23.75bn | 2.32k | 62.00 | 2.13 | -- | 10.95 | 0.6567 | 0.6567 | 3.75 | 19.09 | 0.1202 | 1.00 | 6.45 | 933,249.40 | 2.41 | 5.34 | 3.66 | 7.13 | 29.00 | 40.37 | 20.07 | 26.55 | 2.25 | -- | 0.09 | 24.53 | 3.28 | 12.37 | -6.97 | 10.71 | 33.37 | -- |
Jiangsu Yangnong Chemical Co Ltd | 11.48bn | 1.57bn | 24.67bn | 3.50k | 15.66 | 2.53 | -- | 2.15 | 3.88 | 3.88 | 28.37 | 24.01 | 0.7527 | 4.67 | 5.03 | 3,279,340.00 | 10.27 | 11.33 | 16.50 | 19.40 | 25.19 | 25.70 | 13.65 | 12.08 | 1.30 | -- | 0.2007 | 19.61 | -27.41 | 5.98 | -12.77 | 9.82 | 15.10 | 5.63 |
Zhejiang Sanmei Chemical Industry Co Ltd | 3.61bn | 261.88m | 25.11bn | 1.87k | 94.85 | 4.24 | -- | 6.95 | 0.4336 | 0.4336 | 5.98 | 9.69 | 0.5563 | 7.51 | 9.95 | 1,928,170.00 | 4.03 | 12.05 | 4.53 | 13.90 | 11.52 | 24.92 | 7.25 | 15.04 | 5.85 | -- | 0.05 | 17.12 | 17.84 | 4.12 | -9.44 | -12.64 | 36.99 | -- |
Ningbo Shanshan Co., Ltd | 20.57bn | 1.68bn | 26.01bn | 7.54k | 13.29 | 1.11 | -- | 1.26 | 0.8666 | 0.8666 | 10.72 | 10.41 | 0.4281 | 3.09 | 4.46 | 2,727,075.00 | 3.69 | 5.60 | 5.31 | 8.86 | 17.76 | 22.78 | 8.62 | 12.07 | 1.05 | 44.89 | 0.4205 | 23.16 | 4.84 | 21.28 | -19.42 | 24.60 | 25.81 | 48.62 |
Data as of Mar 13 2024. Currency figures normalised to Cathay Biotech Inc's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
HBM Partners AG (Investment Management)as of 31 Dec 2023 | 35.62m | 8.83% |
China Asset Management Co., Ltd.as of 30 Sep 2023 | 16.79m | 4.16% |
E Fund Management Co., Ltd.as of 30 Jun 2023 | 5.22m | 1.29% |
GF Fund Management Co., Ltd.as of 30 Jun 2023 | 2.90m | 0.72% |
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 1.32m | 0.33% |
The Vanguard Group, Inc.as of 05 Apr 2024 | 1.29m | 0.32% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 1.12m | 0.28% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 430.69k | 0.11% |
Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 412.19k | 0.10% |
CPIC Fund Management Co. Ltd.as of 30 Jun 2023 | 375.63k | 0.09% |
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.